Lumateperone in Pooled Late-Phase Schizophrenia Trials: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

被引：0

作者：

Citrome, Leslie ^{[1
]}

Durgam, Suresh ^{[2
]}

Edwards, John B. ^{[2
]}

Davis, Robert E. ^{[2
]}

机构：

[1] New York Med Coll, Valhalla, NY USA

[2] Intra Cellular Therapies Inc, New York, NY USA

来源：

CNS SPECTRUMS | 2023年 / 28卷 / 02期

关键词：

D O I：

10.1017/S1092852923001761

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：244 / 244

页数：1

共 50 条

[41] Number needed to treat and number needed to harm: Making sense of catie
Citrome, L.
Stroup, T. S.
SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 426 - 426
[42] Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis
Mendes, Diogo
Alves, Carlos
Batel-Marques, Francisco
CNS DRUGS, 2016, 30 (10) : 909 - 929
[43] Misleading StatisticsThe Problems Surrounding Number Needed to Treat and Number Needed to Harm
Jane L. Hutton
Pharmaceutical Medicine, 2010, 24 (3) : 145 - 149
[44] Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials
Hutton, Jane L.
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (01) : 27 - 30
[45] Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm
Citrome, Leslie
Du, Yangchun
Weiden, Peter J.
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 2639 - 2646
[46] The number needed to treat in cardiovascular clinical trials
Curiel, Roberto
Rodriguez-Plaza, Luis
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 114 (03) : 388 - 389
[47] Number needed to treat (NNT) and number needed to harm (NNH): Applying results of randomized clinical trials (RCT) to routine clinical care
Yazici, Y.
Moses, N.
Yazici, H.
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 342 - 342
[48] Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019
Elliott, Marissa H.
Skydel, Joshua J.
Dhruva, Sanket S.
Ross, Joseph S.
Wallach, Joshua D.
JAMA INTERNAL MEDICINE, 2021, 181 (02) : 282 - 284
[49] Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder
Arnaud, Alix
Suthoff, Ellison
Stenson, Katie
Werneburg, Brian
Hodgkins, Paul
Bonthapally, Vijayveer
Jonas, Jeffrey
Meyer, Kellie
O'Day, Ken
JOURNAL OF AFFECTIVE DISORDERS, 2021, 285 : 112 - 119
[50] Evidence-based medicine (EBM) in practice: Applying number needed to treat and number needed to harm
Sierra, F
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (08): : 1661 - 1663

← 1 2 3 4 5 →